Journal of Clinical Endocrinology & Metabolism, Vol 78, 1220-1224, Copyright © 1994 by Endocrine Society

ARTICLES

Effects of growth hormone (GH) administration on functional hepatic nitrogen clearance: studies in normal subjects and GH-deficient patients

T Wolthers, T Grofte, JO Jorgensen, N Moller, N Vahl, JS Christiansen and H Vilstrup
Medical Department M (Endocrinology and Diabetes), Aarhus University Hospital, Denmark.

A decline in serum urea levels and urinary urea excretion is usually seen after GH administration in humans, indicating overall protein anabolism. Whether this reflects the diminished supply of alpha-amino acids for urea synthesis or a substrate-independent hepatic mechanism is unknown. To pursue this we measured the urea nitrogen synthesis rate (UNSR) and blood alanine levels before, during, and after a 4-h constant iv infusion of alanine (2 mmol/kg BW.h). UNSR was estimated hourly as urinary excretion corrected for gut hydrolysis and accumulation in total body water. The slope of the linear relationship between UNSR and circulating alanine levels represents the hepatic components of conversion of amino nitrogen and is denoted the functional hepatic nitrogen clearance (FHNC). Eight male volunteers were randomly investigated on three occasions: 1) after 12-h iv saline infusion, 2) after 12-h iv GH infusion (1 IU/h), and 3) after 2-day sc GH treatment (8 IU/day), followed by 12-h iv infusion of GH (1 IU/h). The UNSR (millimoles per h) during alanine infusion was significantly lower when the subjects were receiving GH therapy [maximum +/- SE, 133.0 +/- 6.9 (saline) vs. 96.7 +/- 11.1 (12-h GH; P < 0.01) vs. 106.5 +/- 7.5 (2-day GH; P < 0.05)]. FHNC (liters per h) was similar in all three studies [30.3 +/- 1.2 (saline) vs. 26.6 +/- 3.4 (12-h GH) vs. 27.0 +/- 2.6 (2-day GH)]. Six GH-deficient adult patients were randomly studied twice: 1) on regular daily (at 2000 h) sc GH therapy (3 IU/m2.day), and 2) after discontinuation of GH for 2 days. The UNSR during alanine infusion was likewise significantly lower when the patients were receiving GH therapy [147.7 +/- 11.7 mmol/h (no GH) vs. 123.9 +/- 9.1 mmol/h; P < 0.01]. FHNC (liters per h) values were similar in the two studies [29.2 +/- 3.8 (GH) vs. 27.5 +/- 4.5 (no GH)]. Our data confirm the anabolic action of GH and show that short term GH deprivation is associated with catabolism in terms of increased UNSR. The finding of unaltered FHNC suggests a GH-induced extrahepatic regulation of amino nitrogen conversion, rather than a substrate- independent hepatic mechanism.

This article has been cited by other articles:

				C. H. Gravholt, H. E. Poulsen, P. Ott, J. S. Christiansen, and H. Vilstrup Quantitative liver functions in Turner syndrome with and without hormone replacement therapy Eur. J. Endocrinol., June 1, 2007; 156(6): 679 - 686. [Abstract] [Full Text] [PDF]

				S. Nielsen, N. Moller, S. B. Pedersen, J. S. Christiansen, and J. O. L. Jorgensen The Effect of Long-Term Pharmacological Antilipolysis on Substrate Metabolism in Growth Hormone (GH)-Substituted GH-Deficient Adults J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3274 - 3278. [Abstract] [Full Text] [PDF]

				K. Ljungmann, T. Grofte, P. Kissmeyer-Nielsen, A. Flyvbjerg, H. Vilstrup, N. Tygstrup, and S. Laurberg GH decreases hepatic amino acid degradation after small bowel resection in rats without enhancing bowel adaptation Am J Physiol Gastrointest Liver Physiol, October 1, 2000; 279(4): G700 - G706. [Abstract] [Full Text] [PDF]

				H. Barle, P. Essen, B. Nyberg, H. Olivecrona, M. Tally, M. A. McNurlan, J. Wernerman, and P. J. Garlick Depression of liver protein synthesis during surgery is prevented by growth hormone Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E620 - E627. [Abstract] [Full Text] [PDF]